Duke Cancer Biologist Kris Wood joins CAI Science Adviser Team
SAN DIEGO, Feb 3, 2017 -- Duke University's Kris Wood is the newest member of the Science Adviser team at Cell Applications, Inc. Anti-cancer drug resistance is the focus for Dr. Wood, an Assistant Professor in the Department of Pharmacology and Cancer Biology at Duke. More specifically, his laboratory group wants to know why well-designed drugs fail, either in the upfront setting or over time. To address this problem, they use custom functional genomic screening technologies alongside primary cellular models of cancer, animal models and the basic tools of biochemistry and genetics. A 2014 Science Signaling article describes this “pathway activation” screening as a strategy to map signaling pathways driving therapeutic resistance, paving the way for subsequent work in his lab and others. Dr. Wood earned his PhD in Chemical Engineering from the Massachusetts Institute of Technology, followed by an NIH Postdoctoral Fellowship at the Whitehead Institute for Biomedical Research, the Broad Institute of Harvard and MIT, and the Howard Hughes Medical Institute. In 2012 Kris joined the Duke University faculty as an Assistant Professor in the School of Medicine, where he is also a member of the Duke Cancer Institute. Dr. Wood is a member of the Board of Associate Scientific Advisors for Science Translational Medicine, and a recipient of the Breakthrough Award, DoD Breast Cancer Research Program.|
Press & Media Relations
Daniel Schroen, PhD
VP, Sales & Marketing
(858) 453-0848
|